Zinc and Tumor Suppression in Prostate Cancer
Author Information
Author(s): Costello Leslie C, Franklin Renty B
Primary Institution: Department of Biomedical Sciences, Dental School, University of Maryland, Baltimore, Maryland, USA
Hypothesis
The role of zinc and its transporter ZIP1 in the metabolism and tumor suppression of prostate cancer cells.
Conclusion
Zinc accumulation in prostate cells is critical for tumor suppression, and its depletion in malignant cells contributes to cancer progression.
Supporting Evidence
- Malignant prostate tissue shows a dramatic decrease in zinc levels compared to normal tissue.
- Zinc accumulation inhibits the growth and proliferation of prostate cells.
- ZIP1 is downregulated in malignant prostate cells, leading to decreased zinc accumulation.
- High zinc levels in normal prostate cells are associated with tumor-suppressive effects.
- Zinc's inhibition of m-aconitase activity prevents citrate oxidation, promoting tumor suppression.
Takeaway
Zinc helps keep prostate cells healthy, and when there's not enough zinc, it can lead to cancer.
Methodology
This review integrates experimental and clinical evidence regarding prostate cancer metabolism and the role of zinc.
Potential Biases
Potential bias in the interpretation of zinc's role due to varying study designs and populations.
Limitations
The review is based on existing literature and may not include all recent findings.
Participant Demographics
The review discusses findings from various studies involving different populations, including racial differences in prostate cancer susceptibility.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website